FIELD: medicine; gynaecology.
SUBSTANCE: vyferon-3 is introduced through rectum by 1 suppository 2 times a day during 10 days followed with laser vaporisation of pathologic focus. Besides, on 4th, 6th and 8th day of treatment rhoncoleukin in introduced in two points of uterine cervix submucosa in total dosage 0.25 mg.
EFFECT: decreased disease relapse and risk of malignant process developing within uterine cervix providing maintenance of reproductive function.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING CERVICAL ECTOPIA | 2014 |
|
RU2568768C1 |
| METHOD OF TREATING BENIGN DISEASES OF CERVIX | 2012 |
|
RU2483720C1 |
| METHOD OF TREATING PAPILLOMA VIRUS INFECTION | 2011 |
|
RU2478390C2 |
| COMPLEX METHOD OF ANOGENITAL POINTED CONDYLOMA TREATMENT | 2007 |
|
RU2341258C1 |
| DIAGNOSTIC TECHNIQUE FOR PAPILLOMA VIRUS INFECTION | 2008 |
|
RU2379690C1 |
| METHOD OF TREATING OF PLANOCELLULAR INTRAEPITHELIAL LESIONS OF CERVIX OF UTERUS | 2014 |
|
RU2552332C1 |
| METHOD FOR TREATING BENIGN DISEASES OF UTERINE CERVIX | 2002 |
|
RU2217186C1 |
| METHOD FOR DYNAMIC CONTROL OF EFFICIENCY OF TREATMENT OF CERVICAL INTRAEPITHELIAL LESIONS OF CERVIX UTERI BY MEANS OF DIINDOLYLMETHANE-BASED SUPPOSITORIES | 2015 |
|
RU2618427C1 |
| METHOD FOR PREVENTING PRECANCER RECURRENCE AND PRIMARY CERVICAL CANCER FOLLOWING ORGAN-PRESERVING TREATMENT BY DIAGNOSING AND TREATING HPV IN ANOGENITAL-OROPHARYNGEAL SPHERE IN SEXUAL PAIRS | 2020 |
|
RU2733934C2 |
| COMPOSITION FOR TREATMENT OF LATENT AND SUBCLINICAL PAPILLOMAVIRUS INFECTION OF CERVIX AND METHOD FOR ITS APPLICATION | 2020 |
|
RU2747987C1 |
